NO153520C - Fremgangsm¨te til fremstilling av et stabilt preparat inne holdende prostaglandin. - Google Patents
Fremgangsm¨te til fremstilling av et stabilt preparat inne holdende prostaglandin.Info
- Publication number
- NO153520C NO153520C NO800186A NO800186A NO153520C NO 153520 C NO153520 C NO 153520C NO 800186 A NO800186 A NO 800186A NO 800186 A NO800186 A NO 800186A NO 153520 C NO153520 C NO 153520C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- procedure
- stable
- containing prostaglandin
- preparation containing
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7900737A SE431821B (sv) | 1979-01-29 | 1979-01-29 | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO800186L NO800186L (no) | 1980-07-30 |
| NO153520B NO153520B (no) | 1985-12-30 |
| NO153520C true NO153520C (no) | 1986-04-09 |
Family
ID=20337129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO800186A NO153520C (no) | 1979-01-29 | 1980-01-25 | Fremgangsm¨te til fremstilling av et stabilt preparat inne holdende prostaglandin. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4352790A (nl) |
| JP (1) | JPS55102512A (nl) |
| BE (1) | BE881351A (nl) |
| DE (1) | DE3001454A1 (nl) |
| DK (2) | DK160739C (nl) |
| FR (1) | FR2447191A1 (nl) |
| GB (1) | GB2041220B (nl) |
| NL (1) | NL190693C (nl) |
| NO (1) | NO153520C (nl) |
| SE (2) | SE431821B (nl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE14979T1 (de) * | 1979-03-21 | 1985-09-15 | Nat Res Dev | Zusammensetzung mit geregelter wirkstofffreigabe und verfahren zu ihrer herstellung. |
| US5079009A (en) * | 1979-03-21 | 1992-01-07 | National Research Development Corporation | Controlled release compositions including polyethylene oxide with urethane cross-linking |
| IT1131833B (it) * | 1980-06-20 | 1986-06-25 | Crinos Industria Farmaco | Eccipienti per sostanze spermicide |
| ZA831186B (en) * | 1982-03-22 | 1983-11-30 | Upjohn Ltd | Gelled pge2/triacetin solutions |
| AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
| US4675182A (en) * | 1983-02-12 | 1987-06-23 | Bayer Aktiengesellschaft | Complexes of prostaglandins |
| DE3307816A1 (de) * | 1983-03-02 | 1984-09-06 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung |
| GB8403360D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
| DE3428264A1 (de) * | 1984-07-27 | 1986-03-06 | Schering Ag | Gelhaltige pharmazeutische zubereitungen |
| IE59361B1 (en) * | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
| JP2590358B2 (ja) * | 1988-03-01 | 1997-03-12 | 正雄 五十嵐 | 子宮内膜症治療用の子宮内又は膣内投与製剤 |
| JPH03220201A (ja) * | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
| CH678697A5 (nl) * | 1989-04-03 | 1991-10-31 | Warner Lambert Co | |
| EP0661052A1 (en) * | 1991-11-08 | 1995-07-05 | Kyoto Pharmaceutical Industries, Ltd. | Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
| US6946442B2 (en) * | 1994-11-30 | 2005-09-20 | Asif Syed Ahmed | Method of hastening cervical ripening |
| EP0828495B1 (en) * | 1995-06-01 | 2002-10-30 | G.D. Searle & Co. | Stabilized solid dispersions of misoprostol |
| US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
| CA2295595A1 (en) | 1997-07-09 | 1999-01-21 | Androsolutions, Inc. | Improved methods and compositions for treating male erectile dysfunction |
| FR2766709B1 (fr) * | 1997-07-31 | 2000-04-07 | Dominique Cingotti | Procede pour la preparation d'un extrait de principes actifs sous forme de microgranules a base de fibres alimentaires entierement solubles destines a differentes formes galeniques |
| US5891915A (en) * | 1998-05-01 | 1999-04-06 | Wysor; Michael S. | Method for enhancing female sexual response and an ointment therefor |
| US6031002A (en) * | 1998-05-01 | 2000-02-29 | Michael Ebert | Method for enhancing female sexual response and a composition therefor |
| US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
| US20070191320A1 (en) * | 1998-12-10 | 2007-08-16 | Nexmed Holdings, Inc. | Methods of treatment for female sexual arousal disorder |
| US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
| GR1004266B (el) * | 2001-04-30 | 2003-06-18 | Ηλιας Κ. Παπαδοπουλος | Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας |
| US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
| US3875300A (en) | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
| US3888975A (en) * | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
| US4036954A (en) * | 1973-11-02 | 1977-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Stable prostaglandin E group-containing formulation |
| AR205997A1 (es) | 1973-11-21 | 1976-06-23 | American Cyanamid Co | Resina de poliester normalmente solida biodegradable e hidrolizable |
| CH616694A5 (en) * | 1974-06-27 | 1980-04-15 | Ciba Geigy Ag | Process for the preparation of crosslinked, water-insoluble, hydrophilic copolymers |
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| JPS5256148A (en) * | 1975-10-16 | 1977-05-09 | Agency Of Ind Science & Technol | Process for preparing active substances having improved |
| GB1554783A (en) | 1976-01-05 | 1979-10-31 | Population Res Inc | Pharmaceutical compositions for use in the permanent sterilization of female animals |
| US4145555A (en) * | 1976-03-12 | 1979-03-20 | Ono Pharmaceutical Company | Δ3 -Prostaglandin analogs |
| GB1551620A (en) * | 1976-12-13 | 1979-08-30 | Ici Ltd | Delivery means for biologically active agents |
-
1979
- 1979-01-29 SE SE7900737A patent/SE431821B/sv not_active IP Right Cessation
- 1979-12-17 SE SE7910354A patent/SE442167B/sv not_active IP Right Cessation
-
1980
- 1980-01-14 GB GB8001176A patent/GB2041220B/en not_active Expired
- 1980-01-16 DE DE19803001454 patent/DE3001454A1/de active Granted
- 1980-01-16 US US06/112,563 patent/US4352790A/en not_active Expired - Lifetime
- 1980-01-18 JP JP519880A patent/JPS55102512A/ja active Granted
- 1980-01-23 NL NL8000426A patent/NL190693C/nl not_active IP Right Cessation
- 1980-01-25 NO NO800186A patent/NO153520C/no unknown
- 1980-01-25 BE BE0/199113A patent/BE881351A/fr not_active IP Right Cessation
- 1980-01-28 DK DK033580A patent/DK160739C/da not_active IP Right Cessation
- 1980-01-28 FR FR8001797A patent/FR2447191A1/fr active Granted
-
1986
- 1986-07-03 DK DK316186A patent/DK160740C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55102512A (en) | 1980-08-05 |
| DK160740B (da) | 1991-04-15 |
| FR2447191B1 (nl) | 1983-07-22 |
| FR2447191A1 (fr) | 1980-08-22 |
| SE442167B (sv) | 1985-12-09 |
| SE431821B (sv) | 1984-03-05 |
| SE7910354L (sv) | 1980-07-30 |
| DE3001454C2 (nl) | 1990-05-10 |
| NO800186L (no) | 1980-07-30 |
| DK160739B (da) | 1991-04-15 |
| NL190693C (nl) | 1994-07-01 |
| US4352790A (en) | 1982-10-05 |
| BE881351A (fr) | 1980-05-16 |
| DE3001454A1 (de) | 1980-08-07 |
| NL190693B (nl) | 1994-02-01 |
| GB2041220A (en) | 1980-09-10 |
| DK160740C (da) | 1991-09-30 |
| DK33580A (da) | 1980-07-30 |
| SE7900737L (sv) | 1980-07-30 |
| DK160739C (da) | 1991-09-30 |
| NL8000426A (nl) | 1980-07-31 |
| JPH0140013B2 (nl) | 1989-08-24 |
| NO153520B (no) | 1985-12-30 |
| GB2041220B (en) | 1983-07-27 |
| DK316186D0 (da) | 1986-07-03 |
| DK316186A (da) | 1986-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO153520C (no) | Fremgangsm¨te til fremstilling av et stabilt preparat inne holdende prostaglandin. | |
| DK146677A (da) | Fremgangsmade til fremstilling af et farmaceutisk preparat indeholdende triazolopyrimidin | |
| NO145817C (no) | Fremgangsmaate ved fremstilling av et sproeytbart germicid preparat | |
| NO157048C (no) | Fremgangsmaate til fremstilling av en tablett. | |
| NO860680L (no) | Fremgangsm¨te for fremstilling av en replikerbar kloningsv ektor. | |
| NO155476C (no) | Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre. | |
| NO772085L (no) | Fremgangsm}te for fremstilling av antibakterielle forbindelser | |
| DK290079A (da) | Fremgangsmaade til fremstilling af prostanoidforbindelser | |
| NO149954C (no) | Kontinuerlig fremgangsmaate til fremstilling av gipsplater | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| SE8001747L (sv) | Forfarande for framstellning av 1-fluorerade vitamin d-foreningar | |
| NO150155C (no) | Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser | |
| NO771277L (no) | Fremgangsm}te for fremstilling av aromatiske uretaner | |
| NO155548C (no) | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. | |
| NO153418C (no) | Fremgangsmaate for fremstilling av et preparat av terapeutisk brukbar galaktomannan. | |
| NO153553C (no) | Fremgangsm¨te for fremstilling av en presset suppositoriem asse. | |
| FI65370B (fi) | Foerfarande foer framstaellning av ett fast farmaceutiskt preparat | |
| NO800570L (no) | Fremgangsmaate til fremstilling av store islegemer | |
| NO152439C (no) | Kontinuerlig fremgangsmaate til fremstilling av gipsplater | |
| NO771871L (no) | Fremgangsm}te til fremstilling av kvadratsyre | |
| NO791599L (no) | Fremgangsmaate for fremstilling av dibenzyletere | |
| NO152254C (no) | Fremgangsmaate til fremstilling av karbazolderivater | |
| SE7800048L (sv) | Forfarande for framstellning av farmaceutiska preparat | |
| NO800251L (no) | Fremgangsmaate til fremstilling av beta-laktamforbindelser | |
| NO791894L (no) | Framgangsmaate for framstilling av kornorientert elektrostaal |